Search clinical trials for: BI 1358894 (Test)

Total 10738 results

Boehringer Ingelheim

Completed

This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Looks at How Food Influences the Amount of BI 1358894 in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test if Taking Different Formulations of BI 1358894 With or Without Food Influences the Amount of BI 1358894 in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How BI 1358894 is Taken up in the Body and How Food Influences the Amount of BI 1358894 in the Blood

Healthy

Netherlands
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How BI 1358894 is Taken up and Handled by the Body

Healthy

Netherlands
Boehringer Ingelheim

Completed

A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder

Post-Traumatic Stress Disorder

United States, Germany, Sweden, Finland, Israel, Poland, Mexico, Croatia
Boehringer Ingelheim

Completed

A Study to Test Different Doses of BI 1358894 and Find Out Whether They Reduce Symptoms in People With Borderline Personality Disorder

Borderline Personality Disorder

Spain, Germany, Sweden, United States, Mexico, Argentina, France, Poland, Australia, Belgium, Bulgaria, Czechia, Denmark, Italy, Japan
Boehringer Ingelheim

Completed

A Study About How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated in Healthy Japanese Men

Healthy

Japan
Boehringer Ingelheim

Completed

A Study in Healthy People to Compare 2 Different Formulations of BI 1358894 Tablets Taken With or Without Food

Healthy

Germany
Boehringer Ingelheim

Terminated

A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression

Depressive Disorder, Major

United States
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test Whether BI 1358894 Reduces Druginduced Panic Symptoms

Healthy

Netherlands
Boehringer Ingelheim

Completed

Relative Bioavailability of Two Newly Developed Tablet Formulations (TF2 and iFF)Compared to BI 1060469 TF1 Formulation, Following Oral Administration (Low and High Dose)in Healthy Female Subjects

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in People With Depression to Test the Effects of BI 1358894 on Parts of the Brain That Are Involved in Emotions

Depressive Disorder, Major

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men and Women to Test if Taking Different Formulations of BI 730357 Tablets Influences the Amount of BI 730357 in the Blood

Healthy

Germany
Boehringer Ingelheim

Terminated

A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

Depressive Disorder, Major

Spain, United States, Canada, Germany, Japan, Argentina, Hungary, France, Australia, Bulgaria, Czechia, Poland, Russian Federation, Slovakia
Boehringer Ingelheim

Completed

Safety and Pharmacokinetics of Single Rising Doses of BI 705564 and Food Effect on BI 705564 in Healthy Male Subjects

Healthy

Germany
Rhode Island Hospital
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

Intervention to Prevent Peer Violence & Depressive Symptoms Among At-Risk Adolescents (iDOVE2)

Depressive Disorder | Violence

United States
Boehringer Ingelheim

Terminated

Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes

Myelodysplastic Syndromes

United States, Germany
Patri-cia Angelica de Miranda Silva Nogueira

Completed

CPAP Versus Bi-level in Chronic Heart Failure (CHF)

Heart Failure
Boehringer Ingelheim

Completed

Relative Bioavailability of BI 201335 Capsule Versus Three Different Oral Solutions

Healthy

Germany
Société des Produits Nestlé (SPN)

Terminated

Evaluation of Probiotic (L.Reuteri) Survival in Presence of Prebiotic Galacto-oligosaccharides

Healthy

Switzerland
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Identification of the Causative Drug in Drug-induced Acute Interstitial Nephritis (IDENIAM)

Acute Interstitial Nephritis | Drug-Induced Interstitial Nephritis

France
Sheba Medical Center

Recruiting

Cognitive Impairments in Psychotic Disorders

Psychotic Disorders | Cognitive Impairment

Israel
Massachusetts Institute of Technology
Massachusetts General Hospital

Not yet recruiting

Investigating the Effects of Social Stress on Brain Imaging (SSBI)

Social Stress

United States
Columbia University
National Institute of Mental Health (NIMH); Massachusetts General Hospital; Dartmouth... and other collaborators

Completed

Mitochondrial Stress, Brain Imaging, and Epigenetics (MiSBIE)

Mitochondrial Diseases

United States
Cancer Research UK
BioInvent International AB; Bloodwise

Completed

BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia

B-cell Lymphoma | Waldenström Macroglobulinemia | Chronic Lymphocytic Leukaemia

United Kingdom
Chinese University of Hong Kong

Not yet recruiting

Facilitating Routine HIV Testing Among MSM by a Subscription-based Self-test Distribution Model

Hiv

Hong Kong
Psychiatric University Hospital, Zurich

Recruiting

Real-Time Assessment of Stress and Stress Response

Stress, Psychological | Stress, Physiological | Psychiatric Disorder | Stress Reaction

Switzerland
Poitiers University Hospital

Completed

Cytokines and Cognitive Decline in Alzheimer's Disease

Alzheimer's Disease

France
University of Zurich

Completed

Effect of Acute Psychological Stress on Glucose Concentrations in Patients With Type 2 Diabetes

Type 2 Diabetes

Switzerland
Children's Hospital Medical Center, Cincinnati
University of Cincinnati

Completed

Improving Sexually Transmitted Infection (STI) Results Notification and Partner Services

Sexually Transmitted Infections

United States
Anglia Ruskin University

Active, not recruiting

New Visual Acuity and Crowding Tests for Better Detection of Amblyopia

Amblyopia

United Kingdom
University of Pennsylvania

Completed

Post-op Crowd Sourcing Health Data Via Text-messaging

Surgery | Opioid Use | Orthopedic Surgery | Neurosurgery | Acute Injuries Knee

United States
University Hospital Plymouth NHS Trust
University of Plymouth

Not yet recruiting

Tolerance in Beekeepers

Bee Sting
Boehringer Ingelheim

Recruiting

A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

Melanoma | Non-small Cell Lung Cancer (NSCLC) | Carcinoma, Squamous Cell of Head and Neck (HNSCC)

Netherlands
Boehringer Ingelheim

Completed

This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How BI 1358894 Affects the Way the Body Breaks Down Midazolam

Healthy

Germany
University of Colorado, Denver
Children's Hospital of Philadelphia; Children's Hospital Colorado

Completed

Use of Esophageal String Test to Understand Symptoms, Inflammation, and Function in Eosinophilic Esophagitis

Eosinophilic Esophagitis

United States
Centre Hospitalier St Anne

Unknown

Abnormal Regulation, Estimation and Cognitive Impacts of Physical Efforts as an Endophenotype of Anorexia Nervosa (CAPANOX)

Anorexia Nervosa

France
Charite University, Berlin, Germany

Recruiting

Early Diagnosis of Native and Device-associated Meningitis

Bacterial Meningitis | Implant Infection | Fungal Meningitis

Germany
University Hospital, Montpellier

Terminated

Response to Social Rejection in Suicidal Behavior (SADS-CS)

Unipolar Depression

France
Boehringer Ingelheim

Not yet recruiting

A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity

Obesity
Boehringer Ingelheim

Withdrawn

A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer

Anal Canal Squamous Cell Carcinoma

Korea, Republic of
University of Southern California
National Cancer Institute (NCI)

Terminated

Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer

Colon Carcinoma | Liver and Intrahepatic Bile Duct Carcinoma | Pancreatic Carcinoma

United States
Boehringer Ingelheim

Active, not recruiting

A Study in People With Advanced Cancer to Test How BI 907828 is Processed in the Body

Solid Tumors

Hungary
Boehringer Ingelheim

Terminated

A Study in Healthy Men to Find the Best Formulation of BI 894416 and to Test How This is Taken up in the Body

Healthy

United Kingdom
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How BI 1015550 is Taken up and Handled by the Body

Healthy

Netherlands
Chinese PLA General Hospital

Active, not recruiting

Neuroimage Genome Study of Neuroplasticity Associated With Microgravity

MRI | Neuroplasticity | Microgravity | Repeatable Battery for the Assessment of Neuropsychological Status

China
Assistance Publique - Hôpitaux de Paris

Completed

Evaluate the Effort Test as a Therapeutic Monitoring Tool in Acute Rhabdomyolyses (EFFORHAB)

Rhabdomyolysis Linked to a Hereditary Disease of Metabolism

France
Boehringer Ingelheim

Completed

This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.

Neoplasms | Carcinoma, Non-Small-Cell Lung

United States, Spain, United Kingdom, Canada, Poland

3

Subscribe